ライフサイエンスコーパス: trans-activator

1 logic manipulator apart from its function as trans-activator.

2 ely repression of genes, by resisting strong trans activators.

3 to selective induction of pro-apoptotic UPR trans-activators.

4 rotein complexes are proposed to function as trans-activators.

5 onstrated that RIPK4 directly regulates IRF6 trans-activator activity and nuclear translocation.

6 UAS1 is bound by the trans-activator Adr1p.

7 s expressing an iron-independent form of the trans-activator, Aft1, a protein that regulates the expr

8 the gene is induced by the same iron-sensing trans-activator, Aft1p, that regulates CCC2 and FET3.

9 osaccharomyces pombe is dependent on certain trans activators and a specific nucleotide sequence, whi

10 ce the role of ATF-1 as a hypoxia-responsive trans-activator and identifies a novel regulatory progra

11 aricella-zoster virus (VZV) is a major viral trans-activator and is essential for viral growth.

12 n-2A2 (BTN2A2) are regulated by the class II trans-activator and regulatory factor X, two transcripti

13 nses with DNA methylation at specific signal trans-activators and regulators of metabolism.

14 g proteins such as Bright, a B-cell-specific trans-activator, and the Drosophila melanogaster dead ri

15 the efficacy of prime editing, base editing, trans-activators, and nuclease activity coupled to homol

16 y repressed in glioblastomas, the absence of trans-activators appears to be key to the production of

17 evidence that VP16 and the promiscuous viral trans-activator (bICP0) are expressed during the escape

18 The human immunodeficiency virus type 1 Rev trans activator binds directly to unspliced viral mRNA i

19 ntly, the EICP0 and IE proteins are powerful trans-activators but do not function synergistically, (i

20 ree promoters were activated by MHC class II trans-activator, but not CREB-binding protein, whereas I

21 Tat, the viral trans-activator, can be endocytosed by uninfected cells

22 The class II trans- activator (CIITA) is the main transcriptional co-

23 Inhibition of class II trans-activator (CIITA) expression prevents embryonic tr

24 Class II trans-activator (CIITA) has been shown to be required fo

25 rated that major histocompatibility class II trans-activator (CIITA) is crucial in mediating interfer

26 critically upon the activity of the class II trans-activator (CIITA) protein.

27 STAT1, IFN-regulatory factor-1, and class II trans-activator (CIITA) to IFN-gamma.

28 tive in the transcription factor or class II trans-activator (CIITA) were used to reveal a requiremen

29 ster regulator of MHC class II, the class II trans-activator (CIITA).

30 e protein, major histocompatibility class II trans-activator (CIITA).

31 of STAT1alpha and induction of the Class II trans-activator, CIITA.

32 stimulating protein 1 (Sp1) as an important trans-activator essential for constitutive activity in c

33 ar factor 1alpha (HNF1alpha) as an obligated trans-activator for PCSK9 gene expression and demonstrat

34 says identified HNF1alpha as the predominant trans-activator for PCSK9 gene working through this sequ

35 bition is achieved through repression of the trans-activator Foxo1.

36 These findings substantiate the trans-activator function of ecDNA and underscore a struc

37 ed in greatly enhanced IRF6 dimerization and trans-activator function.

38 iced AP-2 variant capable of inhibiting AP-2 trans-activator function.

39 To assess whether this powerful trans-activator functions in conjunction with three othe

40 ression of mRNAs encoding the liver-enriched trans activators HNF-1, HNF-4, HNF-3 alpha, and HNF-3 be

41 ine the role played by this lineage-inducing trans-activator in the establishment and maintenance of

42 varicella-zoster virus (VZV), a major viral trans-activator, initiates the virus life cycle and is a

43 al activation of endogenous genes by a viral trans-activator is sufficient to induce gene repositioni

44 reby the human immunodeficiency virus type-1 trans-activator might impair tumor suppressor functions

45 ol AdTet expressing the reverse tetracycline trans-activator (n = 3).

46 ts of HAD, we have used the HIV-1 neurotoxin trans activator of transcription protein (Tat) to invest

47 udies, allowing the protein to function as a trans activator of transcription.

48 ential for virus replication and is a potent trans activator of viral gene expression.

49 Examination of the Rev trans activators of two nonprimate lentiviruses, visna v

50 Furthermore CIITA (trans-activator of class II) of the mouse has been repor

51 Although the role of p53 as a strong trans-activator of gene expression is well known, the co

52 gamma Lys(49) acetylation were blocked using trans-activator of HIV transcription factor 1 peptides c

53 he 26-kDa protein has now been shown to be a trans-activator of late transcription and it is the prod

54 otein and thereby facilitating its role as a trans-activator of the apoB gene.

55 , our data suggest that Ets-1 functions as a trans-activator of the DOR promoter in the neonatal mous

56 Therefore, HNF1alpha is a potent trans-activator of the mouse Oatp4 promoter.

57 ption factors, C/EBP alpha was the strongest trans-activator of the PEPCK-C gene promoter in the NIH3

58 proto-oncogene, c-Myb was investigated as a trans-activator of the topo IIalpha gene.

59 viral replication cycle as a transcriptional trans-activator of the viral long terminal repeat.

60 Sp1 [or related protein(s)] is an important trans-activator of this TATA-less promoter.

61 mmunodeficiency virus (HIV)-specific protein trans-activator of transcription (Tat) can contribute to

62 that the neurotoxic HIV-1 regulatory protein trans-activator of transcription (Tat) continues to be e

63 al and electrophysiological effects of HIV-1 trans-activator of transcription (Tat) in dopamine subty

64 Human immunodeficiency virus type 1 (HIV-1) trans-activator of transcription (Tat) is a small, intri

65 The viral trans-activator of transcription (Tat) protein uses an a

66 he presence of viral proteins, including the trans-activator of transcription (Tat), has been reporte

67 ed a cell-permeable peptide, which we termed trans-activator of transcription (TAT)-AKAD for TAT-conj

68 interaction for the cell-penetrating peptide trans-activator of transcription (TAT).

69 peptide modified to include a TAT sequence (Trans-Activator of Transcription gene in HIV; TAT-4BB) a

70 The trans-activator of transcription or TAT gene from HIV-1

71 Pretreating LPS-injected mice with trans-activator of transcription peptide (TAT)-GILZ, a c

72 D) tagged with a protein transduction domain trans-activator of transcription was transduced in cultu

73 ate-early (IE) and EICP0 proteins are potent trans-activators of EHV-1 promoters; however, in transie

74 ucturally and immunologically highly related trans-activators of the apoB gene.

75 Sp1 (specific protein-1) and Sp3, acting as trans-activators of type I collagen expression in ANF an

76 a null mutant of another endosperm-specific trans-activator Opaque2 (O2) has been shown to be requir

77 disruption of genes for either MHC class II trans-activator or I-A beta) showed no signs of lesion d

78 y is the presence or absence of a particular trans-activator or repressor relevant in determining gen

79 lled prolamin-box (P-box), recognized by the trans-activator P-box binding factor (PBF).

80 OS gene transcription by S-nitrosylating the trans-activator PARP-1 and decreasing its binding and/or

81 get genes, including c-myc, the MHC class II trans-activator, Pax-5, and CD23b.

82 Note that the Switch trans-activator performed optimally when cloned into the

83 -1 subgenomic promoter and the 34-nucleotide trans-activator prevent expression of a reporter gene.

84 inducing survival and cell division; and as trans-activator, prolonging IFN-gamma synthesis through

85 the iron response element (IRE), and of HIV trans-activator protein (Tat) to the HIV trans-activatio

86 d its transcriptional regulator Class II MHC trans-activator protein expressed by a subset of insulin

87 o the arginine-rich motif present in the Tat trans-activator protein of human immunodeficiency virus

88 59-residue stem-loop interacts with the HIV trans-activator protein Tat and other cellular factors t

89 lar factors in addition to the virus-encoded trans-activator protein Tat and the RNA element TAR.

90 groups responsible for interaction with the trans-activator protein Tat, including conformations sim

91 e acidic activation domain of the prototypic trans-activator protein VP16, can itself bind to RPA.

92 th a single vector encoding the tetracycline trans-activator protein, controlled by a constitutive pr

93 The HIV-1 trans-activator protein, Tat, is a potent activator of t

94 only short transcripts in the absence of the trans-activator protein, Tat.

95 and the chimeric TCR, under the control of a trans-activator protein-responsive promoter.

96 The mRNAs of the CCAAT/enhancer-binding trans-activator proteins (C/EBPalpha and C/EBPbeta) serv

97 The Trans-Activator Receptor (TAR) RNA, located at the 5'-en

98 CysLTRs and dicarboxylic acid receptors with trans-activator reporter gene assays.

99 is complete before the binding of end-stage trans-activators, supporting the notion that heritable c

100 using a binary lentivector system i.e., the trans-activator, Switch, and the inducible promoter-tran

101 The 34-nucleotide trans-activator (TA) located within the RNA-2 of Red clo

102 The viral trans-activator Tat and its regulatory partners, P-TEFb

103 nd is repressed in the presence of the viral trans-activator Tat.

104 ding sites for NF-kappaB, Sp1, and the viral trans-activator Tat.

105 Human immunodeficiency virus (HIV)-encoded trans-activator (Tat) acts through the trans-activation

106 ukemia virus type 1 (HTLV-1) transcriptional trans-activator Tax has been demonstrated to have transf

107 y is thought to be associated with the viral trans-activator Tax.

108 man T-cell lymphotropic virus, type (HTLV)-1 trans-activator, Tax, coordinates with cAMP-responsive e

109 The human T-lymphotropic retrovirus type-I trans-activator, Tax, has been shown to interact directl

110 cell lymphotropic retrovirus type I (HTLV-I) trans-activator, Tax, interacts specifically with the ba

111 The early EICP0 protein is a powerful trans-activator that activates all classes of equine her

112 he intein-mediated splicing of an artificial trans-activator that signals to a genetic circuit contai

113 functions as a nuclear viral RNA sensor and trans-activator to bridge innate sensing with chromatin

114 t HFH-1 must compete with other unidentified trans-activators to mediate repression.

115 GBP1 and heart-specific reverse tetracycline trans-activator transgenes, we expressed human CUGBP1 in

116 While the RNA-sequence specific HIV-1 Tat trans-activator was also shown to enhance processivity i

117 ut also revealed Sp2 to be a relatively weak trans-activator with little or no capacity for additive